ROS-triggerable dual nanocoated probiotics for inflammatory bowel disease treatment

Inflammatory bowel disease (IBD), an immune-mediated chronic gastrointestinal disease, is difficult to treat because its specific pathogenic mechanisms are currently unclear, and its recurrence rate is high. Probiotic therapies have been used to treat IBD; however, challenges, including poor digesti...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Guangze Sang, Sizhen Wang, Qiwei Tai, Yunchang Zhang, Xufang Wang, Baoling Yan, Weiwei Jiang, Zhendong Chen, Linhong Sun, Jiao Zhou, Xiaoxian Wu, Zi Ye, Feng Yang, Jun Luo, Beibei Guo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2026-12-01
Edice:	Drug Delivery
Témata:	Inflammatory bowel disease ulcerative colitis probiotics catechin Escherichia coli Nissle 1917
On-line přístup:	https://www.tandfonline.com/doi/10.1080/10717544.2026.2630460
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!